Related Experiment Video
Updated: May 2, 2026

05:06
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
15.2K
Bacterial systems for gene delivery to systemic tumors
Joanne Cummins1, Michelle Cronin, Jan Peter van Pijkeren
1Cork Cancer Research Centre, BioSciences Institute, University College Cork, Cork, Ireland.
Methods in Molecular Biology (Clifton, N.J.)
|February 26, 2014
Summary
Certain bacteria act as natural tumor-targeting gene vectors, delivering therapeutic genes to tumors after intravenous administration. Procedures are detailed for studying these bacteria in vitro and in vivo for cancer therapy.
Area of Science:
- Microbiology
- Biotechnology
- Cancer Research
Background:
- Certain bacteria exhibit natural tropism for tumor environments.
- These bacteria can be engineered as delivery vehicles for gene therapy.
- Intravenous administration in rodent models has shown tumor-specific delivery.
Purpose of the Study:
- To describe methodologies for studying bacteria as tumor-specific gene delivery vectors.
- To evaluate both invasive and noninvasive bacterial strains for therapeutic potential.
- To investigate bacterial replication within tumors and gene transfer to mammalian cells.
Main Methods:
- In vitro studies to assess bacterial behavior and gene transfer.
- In vivo studies in rodent models to confirm tumor specificity and delivery.
- Evaluation of bacterial-mediated transfer of plasmid DNA (bactofection).
Main Results:
- Demonstration of specific bacterial replication within tumor microenvironments.
- Evidence of successful gene or gene product delivery to tumors.
- Confirmation of bacterial-mediated gene transfer to mammalian cells.
Conclusions:
- Bacteria can serve as effective, tumor-specific biological gene vectors.
- Established procedures facilitate the study and development of bacterial-based cancer therapies.
- Bacterial tumor tropism and bactofection capabilities offer promising therapeutic avenues.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Bacterial Translocation and Protein Secretion
1.1K
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
1.1K
Transgenic Plants
7.0K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
7.0K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

